Description: Anagenics Limited, a consumer health company, develops, manufactures, and markets anti-aging products for hair, skin, and wellbeing in Australia, the United States, China, and Japan. It develops and sales FGF5 inhibitor hair health and hair growth products under the evolis, evolis Professional, Lexilis Hybrid, Jo-Ju RED, and Lexilis BLACK brands. In addition, the company markets its products through retailers and wholesalers, as well as through a direct-to-consumer, e-commerce platform. The company was formerly known as Cellmid Limited and changed its name to Anagenics Limited in December 2021. Anagenics Limited was incorporated in 2004 and is based in Sydney, Australia.
Home Page: anagenics.com
AN1 Technical Analysis
55 Clarence Street
Sydney,
NSW
2000
Australia
Phone:
61 2 9221 6830
Officers
| Name | Title |
|---|---|
| Mr. Matthew Dudek | Acting Chief Exec. Officer |
| Mr. Dominic Burg | Chief Operating Officer |
| Ms. Carolyn Heath | Chief Customer Officer & GM of Sales |
| Dr. Graham Robertson | Head of R&D |
| Mr. Scott Mitchell Greasley | Exec. Director |
| Mr. Lee Tamplin B.A. | Company Sec. |
Exchange: AU
Country: AU : Australia
Currency: Australian Dollar (A$)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.7732 |
| Price-to-Sales TTM: | 0.6223 |
| IPO Date: | |
| Fiscal Year End: | June |
| Full Time Employees: | 0 |